Minerva Imaging are pleased to attend the Targeted Radiopharmaceutical (TRP) Summit, June 11-13, 2019, Munich, Germany.
Short about Minerva:
Minerva Imaging is a scientifically driven CRO. We have substantial experience working with targeted radionuclide therapy. Studies can be designed utilizing our catalogue of PDX or cell line derived models established subcutaneously or orthotopically and combined with non-invasive in vivo PET or SPECT imaging.
Our competences build on more than two decades of research within oncology and molecular imaging at the University of Copenhagen and Rigshospitalet, the National University Hospital of Denmark.
We will be happy to meet and discuss options of collaboration. To request a meeting, please complete the contact form below.